Pharmacy Industry Updates: September 2019
Every month, our Industry Relations Director, LeAnn Lewis provides an in-depth industry update to customers. Below, you will find the agenda for the industry update for September. If you have any questions regarding any of the points, contact us here.
- Oklahoma – Effective 09-01-2019, Requires Treatment Type (DSP24)
- Has committed to not generate errors on Treatment Type until 01-01-2020
- Industry push back may delay that date even further.
- Nebraska – Effective 09-03-2019
- Changing from Dr. First to a NIC’s RxGov Platform
- Requires ASAP 4.2A with new fields of Gender, Phone Number, and Patient ID
- New Data Submission Guide is available.
- Account Signup available as of 08-05-2019
- On 07-30-19 Nebraska changed the port from 177330 to 17730 because of problems presented with a 6-digit port.
- Alabama – Gabapentin Schedule V as of 11-18-2019
- Oregon – Effective likely 01-01-2020 (BOP will promulgate rules)
- Require Gabapentin Reporting as a Drug of Concern
- Require Diagnosis Code and “reason for the prescription”
- California – Still waiting on new format of serial number and barcode required by 01-01-2020
- PDMP reporting – required now if serial number is on the form.
- Florida – ASAP V4.2A Accepted now, but required as of 12-19-2019
Potential PDMP Changes
- Utah – Will be moving to NIC’s RxGov in the future
Legislative/Regulatory Reminders for September 2019
- Arizona – Updated rules about what a pharmacist can modify on a controlled substance prescription.
- Oregon – Must post information about the availability of Naloxone.
- Update rules on emergency fills of a controlled substance
- No longer allows multiple prescriptions to be written on the same date
- Requires checking of PDMP data prior to dispensing most controlled substances
- Must provide notice of safe disposal of medication (BOP to develop documentation)
- Prohibited to sell Dextromethorphan to minors without a prescription
- Nebraska – Requires plans to cover medication synchronization with pro-rated co-pays and full dispensing fees.
New Legislative/Regulatory Highlights
- Texas (HB 2088) – Requires written documentation on safe disposal of medications with some exceptions.
- Iowa – New rule which develops exemptions for electronic prescribing, and states a pharmacist is not requirement to verify a script is subject to one of those exemptions.
- Ohio (HB 166) – Big Omnibus Bill with a number of items relates to PBM’s
Get Involved/Get Informed Spotlight
- NCPDP SCRIPT V2017071 Update
- NCPDP Update
- Drug Supply Chain Security Act (DSCSA)
Contact us to ask questions or get more information about these updates.
The organizer of this call is not an attorney, and the presentation on this call does not constitute legal advice. It contains only the opinions and observations of the organizer and its participants. Any use of information contained in this presentation is at the user’s own risk. The organizer will not be available for depositions or testimony in case of litigation.